Serum NfL (sNfL) measured via ultra-sensitive single-molecule arrays (SIMOA) has been observed to be increased in multiple neurological diseases—including neurodegenerative disorders, trauma, and multiple sclerosis (MS)—and strongly correlates with CSF NfL (12–15). This evidence concerns the gene NEFL and myeloid sarcoma.